The Harvard Drug Group's Financial Acquisition - II

The Harvard Drug Group raised a round of funding on April 08, 2010. Investors include Court Square Capital Partners.

Harvard Drug is an independent generics-focused pharmaceutical distributor in the United States with nearly $500 million in annual sales. Harvard Drug supplies generic and branded pharmaceuticals to o…

Articles about The Harvard Drug Group's Financial Acquisition - II: